HomeBAX • NYSE
Baxter International Inc
$34.86
After Hours:
$34.86
(0.00%)0.00
Closed: Mar 3, 5:09:01 PM GMT-5 · USD · NYSE · Disclaimer
StockUS listed securityUS headquartered
Previous close
$34.51
Day range
$34.30 - $35.24
Year range
$28.34 - $44.01
Market cap
17.78B USD
Avg Volume
5.25M
P/E ratio
-
Dividend yield
1.95%
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
(USD)Dec 2024Y/Y change
Revenue
2.75B0.99%
Operating expense
844.00M6.84%
Net income
-512.00M-308.98%
Net profit margin
-18.60-306.90%
Earnings per share
0.58-34.09%
EBITDA
524.00M-10.73%
Effective tax rate
6.33%
Total assets
Total liabilities
(USD)Dec 2024Y/Y change
Cash and short-term investments
1.76B-42.69%
Total assets
25.78B-8.82%
Total liabilities
18.76B-5.30%
Total equity
7.02B
Shares outstanding
511.62M
Price to book
2.53
Return on assets
2.66%
Return on capital
3.35%
Net change in cash
(USD)Dec 2024Y/Y change
Net income
-512.00M-308.98%
Cash from operations
488.00M-8.10%
Cash from investing
-205.00M10.87%
Cash from financing
141.00M104.80%
Net change in cash
334.00M112.88%
Free cash flow
590.88M4,580.20%
About
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Heathcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Founded
1931
Website
Employees
38,000
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu